Castle Biosciences Inc.
(CSTL)
undefined
undefined%
At close: undefined
28.87
0.14%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Net Income | -57.47M | -67.14M | -31.29M | -10.28M | 5.28M | -6.37M | -12.37M |
Depreciation & Amortization | 12.33M | 10.54M | 3.41M | 472.00K | 358.00K | 323.02K | 310.82K |
Stock-Based Compensation | 51.22M | 36.32M | 21.74M | 8.31M | 1.25M | 293.64K | 108.70K |
Other Working Capital | 6.55M | 7.31M | 384.00K | 8.30M | 738.00K | 1.43M | -467.65K |
Other Non-Cash Items | -4.86M | -19.50M | 33.04M | 823.00K | 2.37M | 542.37K | 520.23K |
Deferred Income Tax | -223.00K | -1.88M | -8.74M | 1.40M | -2.28M | 272.42K | -163.29K |
Change in Working Capital | -6.63M | -7.00K | -4.10M | 9.15M | 44.00K | -7.36M | -640.51K |
Operating Cash Flow | -5.63M | -41.66M | -18.98M | 9.87M | 7.01M | -12.29M | -12.23M |
Capital Expenditures | -13.62M | -5.63M | -3.48M | -4.75M | -937.00K | -277.04K | -494.85K |
Acquisitions | - | -26.97M | -63.18M | 3.00K | - | - | - |
Purchase of Investments | -189.07M | -134.69M | - | - | - | - | - |
Sales Maturities Of Investments | 186.50M | - | - | - | - | - | - |
Other Investing Acitivies | 13.00K | 742.00K | 10.00K | 3.00K | - | - | - |
Investing Cash Flow | -16.18M | -166.54M | -66.66M | -4.75M | -937.00K | -277.04K | -494.85K |
Debt Repayment | -142.00K | -122.00K | -8.00K | -27.36M | 20.92M | 5.42M | 8.57M |
Common Stock Repurchased | -5.13M | -1.69M | -781.00K | - | - | - | - |
Dividend Paid | - | - | - | - | - | - | - |
Other Financial Acitivies | -2.16M | 1.64M | 5.43M | 3.21M | 1.44M | 10.38M | 292.71K |
Financial Cash Flow | -2.30M | 1.51M | 5.42M | 305.89M | 88.29M | 15.84M | 8.87M |
Net Cash Flow | -24.11M | -206.69M | -80.22M | 311.01M | 94.37M | 3.27M | -3.86M |
Free Cash Flow | -19.25M | -47.29M | -22.47M | 5.11M | 6.08M | -12.57M | -12.73M |